DETROIT--(BUSINESS WIRE)--Asterand plc (LSE:ATD), a leading provider of human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research, and 5AM Solutions, a life science technology firm, today announce that they have entered into an agreement to develop next generation virtual biobanking software for exclusive use by Asterand and its collaborators. The aim of the project is to enable broad access to geographically distinct biospecimen resources in an easy to use manner, thereby accelerating discovery in human disease research.